Sentiment-Signal
12,3
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Unternehmen & Branche
| Name | GRAIL, Inc. |
|---|---|
| Ticker | GRAL |
| CIK | 0001699031 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 2,16 Mrd. USD |
| Beta | 4,64 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 147,172,000 | -408,351,000 | -11.11 | 2,922,015,000 | 2,577,862,000 |
| 2025-09-30 | 10-Q | 36,194,000 | -88,977,000 | -2.46 | 2,601,031,000 | 2,239,963,000 |
| 2025-06-30 | 10-Q | 35,544,000 | -113,985,000 | -3.18 | 2,702,551,000 | 2,314,643,000 |
| 2025-03-31 | 10-Q | 31,837,000 | -106,213,000 | -3.10 | 2,847,605,000 | 2,413,668,000 |
| 2024-12-31 | 10-K | 125,595,000 | -2,027,005,000 | -63.54 | 2,983,307,000 | 2,503,405,000 |
| 2024-09-30 | 10-Q | 28,652,000 | -125,688,000 | -3.94 | 3,117,954,000 | 2,587,636,000 |
| 2024-06-30 | 10-Q | 31,970,000 | -1,585,337,000 | -51.06 | 3,269,640,000 | 2,695,127,000 |
| 2024-03-31 | 10-Q | 26,721,000 | -218,914,000 | -7.05 | ||
| 2023-12-31 | 10-K | 93,105,000 | -1,465,685,000 | -47.21 | 3,913,814,000 | |
| 2023-10-01 | 10-Q | 20,722,000 | -891,448,000 | -28.71 | ||
| 2023-07-02 | 10-Q | -193,045,000 | ||||
| 2023-06-30 | 10-Q | 22,414,000 | -193,044,000 | -6.22 | ||
| 2023-04-02 | 10-Q | -193,666,000 | ||||
| 2023-03-31 | 10-Q | -193,666,000 | ||||
| 2023-01-01 | 10-K | 55,550,000 | -5,399,098,000 | -173.89 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-08 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -123,502 | 49.92 | -6,164,923.44 | -613,3% | |
| 2026-04-08 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -45,806 | 49.92 | -2,286,525.59 | -227,5% | |
| 2026-04-08 | Ofman Joshua J. | Director, Officer, President | Open Market Sale | -61,665 | 49.92 | -3,078,168.80 | -306,2% | |
| 2026-03-09 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -85 | 46.74 | -3,972.90 | -0,4% | |
| 2026-03-09 | Ofman Joshua J. | Officer, President | Open Market Sale | -2,836 | 47.93 | -135,929.48 | -13,5% | |
| 2026-03-09 | Ofman Joshua J. | Officer, President | Open Market Sale | -101 | 46.74 | -4,720.74 | -0,5% | |
| 2026-03-09 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -7,203 | 47.93 | -345,239.79 | -34,3% | |
| 2026-03-09 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -258 | 46.73 | -12,056.34 | -1,2% | |
| 2026-03-09 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -2,407 | 47.93 | -115,367.51 | -11,5% | |
| 2026-03-05 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -655 | 53.01 | -34,721.55 | -3,5% | |
| 2026-03-05 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -980 | 53.01 | -51,949.80 | -5,2% | |
| 2026-03-05 | Ofman Joshua J. | Officer, President | Open Market Sale | -690 | 53.01 | -36,576.90 | -3,6% | |
| 2026-03-02 | Ofman Joshua J. | Officer, President | Open Market Sale | -779 | 51.75 | -40,313.95 | -4,0% | |
| 2026-03-02 | Ofman Joshua J. | Officer, President | Open Market Sale | -16,223 | 50.09 | -812,533.82 | -80,8% | |
| 2026-03-02 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -9,135 | 50.09 | -457,529.22 | -45,5% | |
| 2026-03-02 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -35,787 | 50.09 | -1,792,402.63 | -178,3% | |
| 2026-03-02 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -1,717 | 51.84 | -89,014.43 | -8,9% | |
| 2026-03-02 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -438 | 51.86 | -22,715.16 | -2,3% | |
| 2025-12-03 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -25,000 | 99.15 | -2,478,817.50 | -246,6% | |
| 2025-12-03 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -1,604 | 97.28 | -156,042.09 | -15,5% | |
| 2025-12-03 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -8,233 | 96.22 | -792,152.09 | -78,8% | |
| 2025-12-03 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -14,807 | 94.43 | -1,398,248.70 | -139,1% | |
| 2025-12-03 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -15,356 | 95.28 | -1,463,092.04 | -145,5% | |
| 2025-12-03 | Ofman Joshua J. | Officer, President | Open Market Sale | -13,000 | 100.00 | -1,300,000.00 | -129,3% | |
| 2025-11-17 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -1,697 | 79.20 | -134,402.40 | -13,4% | |
| 2025-10-16 | Ofman Joshua J. | Officer, President | Open Market Sale | -6,114 | 82.01 | -501,409.14 | -49,9% | |
| 2025-10-15 | Ofman Joshua J. | Officer, President | Open Market Sale | -8,865 | 76.03 | -673,984.67 | -67,0% | |
| 2025-10-15 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -7,239 | 68.88 | -498,622.32 | -49,6% | |
| 2025-10-06 | Ofman Joshua J. | Officer, President | Open Market Sale | -81,385 | 62.50 | -5,086,562.50 | -506,0% | |
| 2025-10-02 | Ofman Joshua J. | Officer, President | Open Market Sale | -9,692 | 64.00 | -620,312.23 | -61,7% | |
| 2025-08-19 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -877 | 32.02 | -28,081.54 | -2,8% | |
| 2025-08-19 | Ofman Joshua J. | Officer, President | Open Market Sale | -4,202 | 32.02 | -134,548.04 | -13,4% | |
| 2025-07-15 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -8,000 | 38.93 | -311,440.00 | -31,0% | |
| 2025-06-30 | Ofman Joshua J. | Officer, President | Open Market Sale | -9,692 | 52.00 | -503,984.00 | -50,1% | |
| 2025-06-12 | Ofman Joshua J. | Officer, President | Open Market Sale | -9,692 | 42.30 | -410,019.09 | -40,8% | |
| 2025-05-02 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -41,150 | 33.93 | -1,396,219.50 | -138,9% | |
| 2025-05-02 | Ofman Joshua J. | Officer, President | Open Market Sale | -48,213 | 33.93 | -1,635,867.09 | -162,7% | |
| 2025-05-02 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -94,035 | 33.93 | -3,190,607.55 | -317,4% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.